Mondelez International
MDLZ
$61.60
-0.71%
Mondelez International is a global leader in the snack food industry, operating primarily in the biscuit, chocolate, gum/candy, beverage, and cheese and grocery categories with iconic brands like Oreo, Cadbury, and Chips Ahoy. The company is a dominant market player with a vast international footprint, deriving significant revenue from developing markets, Europe, and North America, which provides geographic diversification and scale. The current investor narrative centers on navigating persistent input cost pressures and European energy market volatility, as highlighted by recent news, while the company leverages its strong brand portfolio to maintain pricing power and deliver consistent shareholder returns through dividends.…
MDLZ
Mondelez International
$61.60
MDLZ 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Mondelez International's 12-month outlook, with a consensus price target around $80.08 and implied upside of +30.0% versus the current price.
Average Target
$80.08
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$49 - $80
Analyst target range
Analyst coverage is robust with 13 firms providing estimates, indicating strong institutional interest in this large-cap staple. The consensus sentiment leans bullish, as evidenced by recent institutional ratings which include actions like 'Overweight' from Morgan Stanley and 'Outperform' from Bernstein, though there is a notable contingent of 'Neutral' or 'Hold' ratings, reflecting a balanced but cautiously optimistic view. The average target price and implied upside cannot be calculated precisely from the provided data, which includes EPS and revenue estimates but not explicit price targets; however, the presence of both 'Buy' and 'Hold' recommendations with recent reaffirmations suggests analysts see the stock as fairly valued at current levels with moderate upside potential tied to execution. The target range is implied to have some dispersion given the mix of ratings, with high targets likely banking on successful margin recovery and sustained pricing power, while low targets may factor in risks from prolonged inflation, European economic weakness, and competitive pressures.
Bulls vs Bears: MDLZ Investment Factors
The investment thesis for Mondelez International is a classic battle between its defensive, cash-generating business model and severe, persistent margin pressures. The bull case is anchored in the company's strong free cash flow, low volatility, pricing power, and the market's expectation of a significant earnings recovery priced into the forward PE of 18x. The bear case highlights the alarming 1,048 basis point year-over-year gross margin compression, elevated trailing valuation, and concentrated risk from European energy market volatility. Currently, the bearish evidence carries more weight due to the tangible and severe impact of margin erosion on profitability, which directly challenges the earnings recovery priced into the stock. The single most important tension is whether management can successfully restore margins towards historical levels through pricing and operational efficiency, or if the new, lower margin environment is structural, which would necessitate a downward re-rating of earnings expectations and the stock's valuation.
Bullish
- Strong Free Cash Flow & Dividend: The company generates robust free cash flow of $3.24 billion TTM, providing ample coverage for its reliable $0.50 quarterly dividend and share repurchases. This financial strength underpins its defensive appeal and shareholder returns.
- Defensive Low-Beta Profile: With a beta of 0.404, MDLZ is about 60% less volatile than the broader market. This characteristic makes it a resilient holding during market downturns, as evidenced by its positive 6-month return of +11.08% despite a challenging year.
- Pricing Power & Revenue Growth: MDLZ demonstrated strong pricing power with Q4 2025 revenue of $10.50 billion, a 9.29% year-over-year increase. This growth, driven by its iconic global brands, shows resilience against consumer pressures.
- Conservative Balance Sheet: A moderate debt-to-equity ratio of 0.867 indicates a manageable leverage profile. This provides financial flexibility to navigate cost pressures and pursue strategic investments without undue balance sheet risk.
Bearish
- Severe Gross Margin Compression: Gross margin collapsed to 28.16% in Q4 2025 from 38.64% a year ago, a 1,048 basis point contraction. This severe pressure from input and energy costs directly threatens profitability and the earnings recovery narrative.
- Elevated Trailing Valuation: The trailing PE of 28.42x is near the upper end of its historical range and trades at a premium to the consumer staples sector. This leaves little room for multiple expansion and prices in a near-perfect earnings recovery.
- Significant European Exposure Risk: With ~40% of revenue from Europe, the company is acutely exposed to the region's second energy crisis, as highlighted by recent news. This poses a direct, ongoing threat to operational costs and margins.
- Weak Relative Performance: MDLZ has significantly underperformed the market, with a 1-year relative strength of -35.5% versus the S&P 500. This suggests investor skepticism about its ability to overcome margin challenges and deliver growth.
MDLZ Technical Analysis
The stock is in a sustained uptrend over the medium term, evidenced by a 6-month price change of +11.08% and a year-to-date gain of +13.68%. However, it currently trades at a depressed level relative to its 52-week range, with a price of $60.99 sitting just 20.1% above its 52-week low of $51.20 and 14.3% below its 52-week high of $71.15, indicating it is recovering from a significant drawdown but remains far from recent highs. Recent momentum shows a divergence, with a strong 3-month gain of +4.43% contrasting with a slight 1-month decline of -0.60%, suggesting the short-term uptrend may be pausing or consolidating after the recent advance from the March lows near $54. Key technical support is firmly established at the 52-week low area near $51.20, while major resistance looms at the 52-week high of $71.15; a breakout above this level would signal a resumption of the long-term bull trend. The stock exhibits low market-relative volatility with a beta of 0.404, meaning it is about 60% less volatile than the broader market, which is characteristic of a defensive consumer staples name and influences position sizing for risk-averse portfolios.
Beta
0.40
0.40x market volatility
Max Drawdown
-27.2%
Largest decline past year
52-Week Range
$51-$71
Price range past year
Annual Return
-6.9%
Cumulative gain past year
| Period | MDLZ Return | S&P 500 |
|---|---|---|
| 1m | +0.1% | +0.2% |
| 3m | +8.9% | +9.2% |
| 6m | +14.3% | +7.5% |
| 1y | -6.9% | +23.4% |
| ytd | +14.8% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MDLZ Fundamental Analysis
Revenue growth remains positive but has shown volatility, with Q4 2025 revenue of $10.50 billion representing a solid 9.29% year-over-year increase; however, examining sequential quarters reveals inconsistency, as Q3 2025 revenue was $9.74 billion and Q2 was $8.98 billion, indicating quarterly fluctuations likely tied to seasonality and pricing actions. The company is solidly profitable, reporting Q4 2025 net income of $665 million and a gross margin of 28.16%, but margins have compressed significantly from the year-ago period's Q4 2024 gross margin of 38.64%, highlighting ongoing pressure from commodity and operational costs. Profitability metrics are adequate but not stellar, with a Return on Equity of 9.49% and a Return on Assets of 3.43%, reflecting the capital-intensive nature of the business and the impact of recent margin headwinds on bottom-line returns. The balance sheet is conservatively managed with a debt-to-equity ratio of 0.867, indicating moderate leverage, and the company generates robust cash flow, evidenced by trailing twelve-month free cash flow of $3.24 billion, which amply covers dividend payments and provides flexibility for share repurchases and strategic investments.
Quarterly Revenue
$10.5B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.28%
Latest Quarter
Free Cash Flow
$3.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MDLZ Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is elevated at 28.42x, while the forward PE is significantly lower at 18.01x, indicating the market expects a substantial recovery in earnings over the next twelve months, likely driven by easing cost pressures and operational improvements. Compared to sector averages, Mondelez trades at a premium; for instance, its forward PE of 18.01x is above typical consumer staples averages in the mid-teens, a premium that may be justified by its superior global brand portfolio, consistent cash flow generation, and defensive characteristics during economic uncertainty. Historically, the current trailing PE of 28.42x is near the upper end of its own range over recent years, as data shows historical PEs fluctuating from lows near 11.44x to highs above 54.90x; this positioning suggests the stock is not cheap on a trailing basis and that much of the anticipated earnings recovery is already priced in, leaving limited room for multiple expansion.
PE
28.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~55x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is severe and ongoing margin compression, with gross margin falling from 38.64% to 28.16% year-over-year in Q4. This 1,048 basis point contraction directly pressures net income, which fell from $1.75 billion to $665 million over the same period. While the company maintains moderate leverage (D/E of 0.867) and strong cash flow ($3.24B FCF TTM), its profitability metrics are currently weak, with a Return on Equity of 9.49% and Return on Assets of 3.43%. The payout ratio exceeding 100% (1.015) indicates dividends are not fully covered by current earnings, relying on cash flow, which could be pressured if margins do not recover.
Market & Competitive Risks: The stock trades at a premium valuation with a forward PE of 18.01x, above typical consumer staples averages, making it vulnerable to multiple compression if earnings growth disappoints. Its significant exposure to Europe (~40% of sales) is a major external risk, as a second energy crisis in the region, per recent news, could sustain elevated input costs and further pressure margins. Competitive risks include potential market share loss to private label brands if aggressive pricing to protect margins leads to consumer pushback. The stock's low beta (0.404) offers defensive characteristics but also limits upside participation in strong bull markets, as seen in its -35.5% 1-year relative strength versus the S&P 500.
Worst-Case Scenario: The worst-case scenario involves a prolonged European energy crisis and global commodity inflation preventing any meaningful margin recovery. This would lead to consistent earnings misses, analyst downgrades, and a de-rating of the forward multiple from 18x towards the sector average in the mid-teens. Concurrently, a broader market sell-off could trigger flight from premium-valued staples. This scenario could realistically drive the stock back to its 52-week low of $51.20, representing a downside of approximately -16% from the current price of $60.99. A more severe bear case, incorporating a historical max drawdown of -27.19%, suggests a potential trough near $44, though this is less likely given the company's strong cash flow and brand moat.